RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 119 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $0 | – | 23 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Abbot Financial Management, Inc. | 1,411,775 | $25,243,000 | 11.48% |
Flagship Pioneering Inc. | 38,506,526 | $688,497,000 | 7.21% |
Artal Group S.A. | 4,155,625 | $74,303,000 | 1.66% |
HARBOURVEST PARTNERS LLC | 986,878 | $17,645,000 | 1.66% |
Nan Fung Group Holdings Ltd | 56,768 | $1,015,000 | 0.32% |
Lombard Odier Asset Management (Switzerland) SA | 245,013 | $4,381,000 | 0.27% |
Bellwether Advisors, LLC | 29,383 | $525,000 | 0.18% |
PDT Partners, LLC | 65,991 | $1,180,000 | 0.08% |
Virtus ETF Advisers LLC | 7,478 | $134,000 | 0.06% |
HITE Hedge Asset Management LLC | 24,911 | $445,000 | 0.06% |